Updated:
CODA Biotherapeutics
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform. The platform controls neuronal...
Overview
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform. The platform controls neuronal activity to treat intractable diseases by modifying target populations with gene therapy. This involves expressing a tunable ligand-gated ion channel in neurons that responds to a proprietary small molecule.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
South San Francisco
Corporate office
South San Francisco, CA, United States
Sector focus
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: